This study assessed the frequency of the KIR and HLA-C genes in COVID-19 patients infected in the early phase of the pandemic and healthy people living in Wuhan, China, and identified specific protective or susceptible KIR/HLA-C gene pairings. The gene discussed is KIR3DL1; the disease is COVID-19.